Share this link via:
Global Empty Capsules Market size was valued at around 3.81 billion in 2023 and is expected to reach a value of USD 5.19 billion by 2032, at a CAGR of 5.9% over the forecast period (2024–2032).
Several major drivers contributing to the expansion of the capsule market are fast growth in aged population, which subsequently has reflected in a high demand for pharmaceuticals. Due to easier ingestion and dissolution rate than that of tablets, today more people are preferring capsules rather than tablets. Cosmeceutical, nutraceutical, and pharmaceutical sectors also have been at the forefront in the market regarding rising demand for capsules.
Capsules dissolve rapidly, therefore they tend to absorb things rapidly, thus most consumers find them because they are easily digestible by tasteless and odourless Gelatine coats. Because some active ingredients from encapsulated drugs get protected by the harsh environment of the digestive system, thereby raising their bioavailability, these reasons are more prominent in majority nutraceuticals and cosmeceuticals preferring a medicine in its capsule form. Capsules can also be prepared in a way that the active ingredient is released very slowly over a set period of time or to a particular area of the body to increase the absorption of drugs.
Another important aspect driving the empty capsules market is that capsules are faster acting compared to tablets. Capsules could be slightly more effective than tablets since they provide a higher bioavailability, through which more drugs can be introduced into the blood. Additionally, capsules make medicines easier to ingest as they release both liquid and solid dosages.
The market scope is segmented because of by Product, by Therapeutic Application, by End Use.
Based on the Product of the market is segmented into Gelatine, Non-Gelatine.
In the year 2023, Gelatine held the highest market share with a sales share of 73.5%. Products available are pig meat Gelatine, bovine Gelatine derived from bones, bone meal Gelatine, and other Gelatine-based empty capsule products, which are protein-based pills, tasteless, gluten-free, and GMO-free. They can be tailored according to one's specific needs and may appeal to specific populations by varying their colour, shape, or size.
During the projection period, the non-Gelatine capsules category would register the maximum growth rate, and non-Gelatine capsules are commercially available in two basic types - pullulan obtained from the tapioca root, and cellulose-based, called HPMC. Since it is derived from vegetable cellulose, its demand is increasing as a substitute to the non-vegetarian or Gelatine capsule, specially while formulating vegan or vegetarian products.
Based on the Therapeutic Application of the market is segmented into Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Antianemic Preparations (Hematenic Preparations), Anti-Inflammatory Drugs, Cardiovascular Therapy Drugs, Cough and Cold Preparations, Other therapeutic applications.
In the antibiotic and antibacterial drug segment, the market was dominated and hence held the largest revenue share in 2023. The most commonly used antibacterial drugs include nitrofurantoin, sulfonamide, tetracycline, and penicillin. There will be a higher demand for antibiotics and antibacterial drugs for increasing bacterial infections, tuberculosis, bladder infections, and gastrointestinal infections. The market is also growing due to an increase in research and development efforts for antibiotics and antibacterial medications.
In the forecast period, vitamins and dietary supplements are expected to have the highest CAGR. This is attributed primarily to an increase in vitamin and dietary supplement usage, user-friendliness, growing acceptability of dietary supplements, the rise in necessity for vitamin products due to an alteration in lifestyles, and growing awareness of health and fitness among people, further increasing demand for these products.
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA are provided by the study. In 2023, North America is dominated in the market by an empty capsule’s revenue share of 34.7%. Several large facilities are used for production in North America as well as various significant capsule manufacturing sites. Pharmacies from all over the world can be found in North America. The most innovative technologies in the pharmaceutical industry led to the most growth in the region.
U.S. Market Trends for Empty Capsules
In 2023, The U.S. market for empty capsules dominated the North American market because of the rise in health issues such as obesity, arthritis, and cancer, which led to a high demand for nutraceuticals to prevent these serious illnesses. Moreover, the market is expanding due to growing customer preferences for personalized dietary supplements and health solutions that are easier to manufacture and take in capsule form as opposed to tablets or powders.
European Market Trends for Empty Capsules
In 2023, the market for empty capsules was found to be quite profitable in Europe. A major market for empty capsules, the region has a thriving pharmaceutical industry, several multinational corporations, and research institutions. Europe's robust pharmaceutical regulations guarantee the market for empty capsules is held to high standards.
With advancements in technology of capsules- including sustainable, biodegradable solutions-the UK market for empty capsules is projected to grow fast in the future years, garnering interest not only from the manufacturers but from the consumers. Drugs, largely presented in an empty capsule format, are more and more demanded with the greying population, and the number of chronic conditions such as diabetes and heart ailments on the increase.
Trends in the Asia Pacific Empty Capsules Market
It is expected that during the forecast period, the market for empty capsules in Asia Pacific would grow at the fastest CAGR. The market is growing due to support from government programs, growth in the pharmaceutical industry, and rapid advancement of the healthcare industry. Further supporting market growth are the increasing trends in cosmeceuticals and nutraceuticals as well as the growing demand for healthy lifestyles.
China holds an important portion of the empty capsules market with large market shares for the year 2023. China serves as a primary manufacturing hub since there are wide range pharmaceutical and nutraceutical business networks operating through the nation. Most such firms formulate products from empty capsules. The growing trend of this country's market propels towards setting up cheaper quality facilities that produce empty capsules. Furthermore, the empty capsules market is expected to increase in pace owing to the healthy policies of the Chinese government, which includes healthcare infrastructure and other incentives for pharmaceutical manufacturing.
Key Findings:
In March 2024, for more than $1 billion, Lonza and Roche agreed to buy Genentech's biologics production facility in California. This is expected to make Lonza one of the biggest locations in the world and greatly improve its capacity to manufacture biologics. To meet the demands of next-generation mammalian biologics medicines, Lonza plans to invest up to USD 600 million in modernizing the facility and enhancing its capabilities.
The report will cover the qualitative and quantitative data on the global Empty Capsules Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Study Period | 2024-32 |
Base Year | 2023 |
Estimated Forecast Year | 2024-32 |
Growth Rate | CAGR of 5.9% from 2024 to 2032 |
Segmentation | By Product, By Therapeutic Application, By End Use, By Region |
Unit | USD Billion |
By Product |
|
By Therapeutic Application |
|
By End Use |
|
By Region |
|
North America accounted for the highest xx% market share in terms of revenue in the Empty Capsules market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Empty Capsules. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Empty Capsules companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Empty Capsules Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Empty Capsules Market Report is also available for below Regions and Country Please Ask for that
Empty Capsules Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends:
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
+1 724 648 0810 +91 976 407 9503 sales@intellectualmarketinsights.com
20 Mar 2023